The following Management's Discussion and Analysis of Financial Condition and
Results of Operations and other parts of this Quarterly Report on Form 10-Q
("Quarterly Report") describe the principal factors affecting the financial
results, liquidity, capital resources and critical accounting estimates of Cyren
LTD ("Cyren," "we," "our," "us," or the "Company"), and should be read in
conjunction with the information contained in our consolidated financial
statements and the notes thereto. The following discussion and analysis includes
forward-looking statements that involve certain risks and uncertainties,
including, but not limited to, those described in Item 1A. Risk Factors in our
most recent Annual Report on Form 10-K (the "2021 Annual Report"). Our actual
results may differ materially from those discussed below. See "Special Note
Regarding Forward-Looking Statements" below.

OVERVIEW

Cyren was an early pioneer and leading innovator of cloud-delivered Software-as-a-Service (SaaS) cyber security solutions that protect businesses, their employees and customers against threats from email, files, and the Internet.



We believe our cloud-based approach to security sets us apart from other vendors
in the market. Our security solutions are engineered around the fundamental
belief that cyber security is a race against time - and the cloud best enables
the speed, sophistication, and advanced automation needed to detect and block
threats as they emerge. As more and more businesses move their data and
applications to the cloud, they need a security provider that is able to keep
pace.

Security threats are more prevalent and stealthier than ever. As cybercrime has
become more sophisticated, every malware, phishing, and ransomware variant is
unique, making it more difficult to detect attacks. While organizations have
traditionally protected their users with gateway security appliances at the
network perimeter, more frequent and evasive attacks combined with a more
distributed workforce are reducing the effectiveness of this approach.
Traditional appliances lack the real-time threat intelligence and processing
power to detect emerging threats, and the growth of mobile devices and an
increasingly distributed workforce means that more and more business is
conducted outside of the traditional network perimeter. As a result, when new
attacks appear in a matter of seconds, legacy cybersecurity products can leave
companies vulnerable for hours, days or even weeks.

Cyren's cloud security products and services fall into three categories:



•Cyren Threat Detection Services - these services detect a variety of threats in
email, files, and from the Internet, and are embedded into products from the
world's leading email providers, cyber security vendors and managed service
providers. Cyren Threat Detection Services include our Email Security Detection
Engine, Malware Detection Engine, Web Security Engine, and Threat Analysis
Service.

•Cyren Threat Intelligence Data - these products provide valuable threat
intelligence data that can be used by enterprise or original equipment
manufacturer (OEM) customers to support threat detection, threat hunting, and
incident response. Cyren's Threat Intelligence offerings include IP Reputation
Intelligence, Phishing Intelligence, Malware Intelligence, and Zombie
Intelligence.

•Cyren Enterprise Email Security Products - these include cloud-based solutions
designed for enterprise customers and are sold either directly or through
channel partners. Cyren Enterprise Email Security products include Cyren Email
Security, a cloud-based secure email gateway, and Cyren Inbox Security, an
anti-phishing product for Microsoft 365.

Cyren GmbH



On June 1, 2022, we entered into a definitive Sale and Purchase Agreement (the
"SPA") with Content Services Group GmbH to sell all the equity interests in our
legacy secure email gateway business and wholly owned subsidiary, Cyren GmbH
(the "Cyren GmbH Transaction").

On August 1, 2022, the Company completed the Cyren GmbH Transaction and received
the initial €9.4 million payment (equivalent to $9.6 million as of the closing
date). Under the terms of the SPA, a holdback in the amount of €0.7 million (the
"Holdback Amount") is currently held in an escrow to satisfy certain claims. The
Holdback Amount, less deductions for claims against the Company, if any, will be
released to the Company no later than twelve months after the closing date.

                                      -22-
--------------------------------------------------------------------------------
  Table of Contents
Subsequent to the closing date, the Company paid approximately $1.4 million in
expenses associated with the Cyren GmbH Transaction. Furthermore, the Company
estimates that the final purchase price will be reduced by $0.4 million based on
working capital and other adjustments and has accrued a current liability as of
September 30, 2022. Beyond that, the Company is using the proceeds from the sale
for working capital and general corporate purposes.

Key Opportunities and Challenges

Threat Landscape



The last several years have possibly experienced the greatest amount of dramatic
global incidents directly related to malware and cyber threats since the advent
of the Internet. From election hacks to global ransomware attacks, malware
threats are at an all-time high. Phishing attacks have become increasingly
common, and no company, large or small seems immune to these threats. Hackers
have become more successful at monetizing these attacks, and as long as these
activities prove lucrative, we expect these incidents to continue.

Cloud and Mobility



Businesses are experiencing a significant change in their IT strategies as they
look to drive more business value, agility and better customer experiences,
while cloud and mobility are becoming increasingly important, as evidenced by
the following trends:

•Business Internet traffic continues to increase every year;

•Data and applications are increasingly moving to the cloud;

•More and more users are working remotely, particularly since the COVID-19 pandemic;

•Businesses continue to move away from traditional on-premise solutions;

•Mature and legacy on-premise deployments are reaching end of life and are increasingly being replaced by cloud and SaaS alternatives;

•IT security teams have experienced staffing shortages;

•Increasingly fast, sophisticated, expensive and high-profile attacks target organizations of all sizes;

•Compliance and regulatory mandates have increased;

•Cybercrime activity among commercial enterprises and nation states has heightened;

•Automation is increasingly considered critical to accelerating detection and protection; and

•Businesses need to simplify operations through vendor consolidation.

Given these trends, Cyren's vision for 100% cloud security is compelling to IT security teams looking to protect their businesses in today's cloud-centric mobile-first world.

Investments in Operations, Research and Development and Sales and Marketing



Our cost of revenues, research and development expenses, and sales and marketing
expenses are all significant contributing factors to our operating losses. Over
time, we expect we will increase utilization of our cloud infrastructure which
we expect will provide the opportunity for improved gross margins. We believe
that our investments in research and development are required in order to
enhance and improve our solutions. In the future, we expect to lower the rate of
research and development investment as a percentage of revenue. The return on
our sales and marketing investment is tied to attracting new customers and
enhancing our business with existing customers, thereby lowering the overall
sales and marketing costs as a percent of revenues. We otherwise continue to
monitor and, where possible, reduce expenses. We believe managing future
headcount and expense growth will be key in improving our gross and operating
margins over time given longer-term declining revenue trends.

                                      -23-
--------------------------------------------------------------------------------
  Table of Contents
Growing Our Enterprise Business

Cyren has prioritized growing its enterprise revenues. With the mid-2020 release
of our anti-phishing solution, Cyren Inbox Security, we believe helping
enterprises mitigate phishing attacks is our most significant revenue growth
opportunity. Given the substantial size of the enterprise anti-phishing market,
Cyren believes this new revenue stream has the potential to grow faster than our
legacy OEM business. As this Cyren Inbox Security business grows, it has the
potential to eventually contribute to a larger portion of our overall revenue,
and longer term, we expect deferred revenue to increase and our operating
results and cash flow to improve.

Components of our Operating Results

Revenue



We derive revenues from the sale of real-time cloud-based services for each of
Cyren's email security, threat detection services and threat intelligence data
product offerings.

We sell all of our solutions as subscription services, either to OEMs and service providers or directly or indirectly to enterprises.

Cost of Revenue



Personnel costs, which consist of salaries, benefits, bonuses and share-based
compensation for employees who operate our network and provide support services
to our customers, as well as data center costs, are the most significant
components of our cost of revenues. Other costs include third-party contractors,
royalties for use of third-party technologies, amortization of intangibles and
depreciation of data center equipment.

Operating Expenses



Our operating expenses consist of research and development, sales and marketing,
and general and administrative expenses. Personnel costs, which consist of
salaries, benefits, bonuses and share-based compensation, are the most
significant component of our operating expenses. Operating expenses also include
allocated overhead costs for facilities, IT and depreciation. We expect
operating expenses to increase in absolute dollars as we continue to grow.

Research and Development
Research and development expenses consist primarily of personnel costs and
outsourced engineering services. We believe these investments are crucial for
our ability to continue to enhance the functionality of our services, as well as
to develop and introduce new services to the market. Development costs related
to internal use technology that supports our security services are capitalized
on the balance sheet, while other development costs are expensed as they are
incurred.

Sales and Marketing
Sales and marketing expenses primarily include personnel costs, sales
commissions, marketing activities, and travel associated with sales and
marketing. We market and sell our services worldwide through our sales
organization and distribution channels. We capitalize sales commissions paid to
internal sales personnel and amortize these expenses over an estimated period of
benefit that reflects the expected future revenue streams. Sales and marketing
expenses have increased in 2022 as we have enhanced our efforts to support
further growth and invested in strategies related to new products launched in
2020. Newly hired sales personnel are typically not immediately productive, and
therefore the increase in expenses we incur when adding personnel is not
immediately accompanied by increased revenue and in some cases may not result in
increased revenue if these new sales personnel are unsuccessful in becoming
productive.

General and Administrative
General and administrative expenses consist primarily of personnel costs, audit
fees, legal expenses, recruiting expenses and other general operating costs. We
expect our general and administrative expenses to continue to grow in absolute
dollars as we continue our business pursuits.

Other Income (Expense), net

Other income (expense), net generally consists of capital gain or loss from the sale of assets.


                                      -24-
--------------------------------------------------------------------------------
  Table of Contents
Financial Expenses, net

Financial expenses, net primarily consists of foreign exchange gains and losses,
interest expense on our outstanding debt, and interest income earned on our cash
and cash equivalents. In 2021 and 2022, these expenses also included income
related to the accounting for a multi-year arrangement where a customer paid
upfront the full contract value. This has been deemed a significant financing
component under Accounting Standards Codification ("ASC") 606, Revenue
Recognition.

Tax Benefit



Our tax benefit is derived primarily from income taxes in foreign jurisdictions
in which we conduct business. We estimate income taxes in each of the
jurisdictions in which we operate. This process involves determining income tax
expense together with calculating the deferred income tax expense related to
temporary differences resulting from the differing treatment of items for tax
and accounting purposes. Deferred tax assets and liabilities are measured using
enacted tax rates in effect for the year in which those temporary differences
are expected to be recovered or settled. These temporary differences result in
deferred tax assets and liabilities, which are included net as applicable within
our balance sheets. For most of our recent years, we have incurred operating
losses in Israel and the U.S., where we have recorded a full valuation allowance
against our deferred tax assets in those jurisdictions.

                                      -25-

--------------------------------------------------------------------------------

Table of Contents

RESULTS OF OPERATIONS

The following table sets forth our financial results for the three and nine months ended September 30, 2022, and 2021:



                                                      Three Months Ended                                                                  Nine Months Ended
                                                         September 30,                                                                      September 30,
                                         2022                                     2021                                     2022                                      2021
(Unaudited and USD in                             % of                                     % of                                      % of                                      % of
thousands)                  Amount              Revenue*             Amount              Revenue*              Amount              Revenue*              Amount              Revenue*

Revenues                  $  5,834                    100  %       $  5,616                    100  %       $  17,302                    100  %       $  18,166                    100  %
Cost of revenues             3,015                     52             3,311                     59              9,677                     56              9,941                     55

Gross profit                 2,819                     48             2,305                     41              7,625                     44              8,225                     45

Operating expenses:
Research and development,
net                          3,449                     59             3,516                     63             11,174                     65             10,606                     58
Sales and marketing          2,705                     46             2,447                     44              7,677                     44              7,097                     39
General and
administrative               2,178                     37             2,162                     38              6,972                     40              6,262                     34

Total operating expenses     8,332                    143             8,125                    145             25,823                    149             23,965                    132

Operating loss              (5,513)                   (94)           (5,820)                  (104)           (18,198)                  (105)           (15,740)                   (87)

Other income (loss), net        (4)                     -                 4                      -                 (6)                     -                (13)                     -
Financial income
(expenses), net                 (7)                     -              (282)                    (5)               104                      1               (705)                    (4)
Loss before taxes on
income                      (5,524)                   (95)           (6,098)                  (109)           (18,100)                  (105)           (16,458)                   (91)
Tax benefit (expenses)           1                      -               (20)                     -                 12                      -                 43                      -

Net loss from continuing
operations                $ (5,523)                   (95) %       $ (6,118)                  (109) %       $ (18,088)                  (105) %       $ (16,415)                   (90) %
Income (loss) from
operations of
discontinued operations,
including loss on
classification as held
for sale                      (575)                   (10) %            331                      6  %          (6,929)                   (40) %             843                      5  %

Net loss                  $ (6,098)                  (105) %       $ (5,787)                  (103) %       $ (25,017)                  (145) %       $ (15,572)                   (86) %

* Percentages may not sum to 100% due to rounding.

As of September 30, 2022, we employed a total of 157 employees compared to 203 employees as of September 30, 2021. Effective August 1, 2022, 37 employees transitioned with Cyren GmbH as part of the Cyren GmbH Transaction.

Revenues



For the three months ended September 30, 2022, revenues increased $0.2 million,
or 3.9%, compared to the same period in 2021. Revenue from our OEM business
increased 1.7% resulting from growth of our Threat Intelligence Service
solution. Revenue from our Enterprise business increased 48.7%, as our Cyren
Inbox Security solution continued to generate year-over-year sales growth.

                                      -26-
--------------------------------------------------------------------------------
  Table of Contents
For the nine months ended September 30, 2022, revenues declined $0.9 million, or
4.8% compared to the same period in 2021. The decrease was mainly driven by a
contract reduction from our largest customer (as first disclosed in our Form
10-Q for the quarter ended September 30, 2020), which was effective in the
second quarter of 2021. The revenue impact of this contract reduction was $0.7
million. Additionally, revenue was adversely impacted by customer contract
expirations or renewals at lower values coupled with the end of life of several
legacy products that began during 2020. These declines were partially offset by
new customers added in 2021 and 2022 in our Threat InDepth and Cyren Inbox
Security products.

We released Cyren Inbox Security and Threat InDepth in the second quarter of
2020. Since these product launches, we have signed numerous new customer
contracts representing over $3.8 million in estimated revenue over the lives of
the contracts, but due to the timing, duration and ratable nature of the
contracts, we did not recognize a material amount of related revenue for the
nine months ended September 30, 2022.

Cost of Revenues



For each of the three and nine months ended September 30, 2022, cost of revenues
declined $0.3 million, compared to the same periods in 2021. These declines were
driven by favorable foreign exchange effects. Furthermore, certain hardware and
software assets that support our products became fully depreciated during the
periods. These declines were partially offset by an increase in costs associated
with maintaining our data center operations.

As of September 30, 2022, we employed 23 employees within cost of revenues compared to 32 employees as of September 30, 2021. Effective August 1, 2022, nine employees transitioned with Cyren GmbH as part of the Cyren GmbH Transaction.

Operating Expenses



For the three months ended September 30, 2022, operating expenses increased $0.2
million, or 2.5%, compared to the same period in 2021, driven by an increase in
marketing expenses of 0.3 million, or 10.5%, partially offset by a decline in
research and development, net of $0.1 million, or 1.9%, while general and
administrative expenses remained relatively flat. For the nine months ended
September 30, 2022, operating expenses increased $1.9 million, or 7.8%, compared
to the same period in 2021, the result of increases in general and
administrative expenses of $0.7 million, or 11.3%, marketing expenses of $0.6
million, or 8.2%, and research and development of $0.6 million, or 5.4%.

Research and Development, Net



For the three months ended September 30, 2022, research and development declined
$0.1 million, or 1.9%, compared to the same period in 2021. This decline was
largely the result of lower compensation expenses. For the nine months ended
September 30, 2022, research and development increased $0.6 million, or 5.4%,
compared to the same period in 2021. This increase was driven primarily by the
reduction in capitalization of technology development, which has the effect of
increasing expenses.

As of September 30, 2022, we employed 78 employees within research and
development compared to 111 employees as of September 30, 2021. Effective August
1, 2022, 23 employees transitioned with Cyren GmbH as part of the Cyren GmbH
Transaction.

Sales and Marketing

For the three months ended September 30, 2022, sales and marketing expenses
increased $0.3 million, or 10.5%, compared to the same period in 2021. For the
nine months ended September 30, 2022, sales and marketing expenses increased
$0.6 million, or 8.2%, compared to the same period in 2021. These increases were
driven by our usage of global demand generation programs and consultants in an
effort to increase sales and marketing efforts to support the growth of the
Cyren Inbox Security product.

As of September 30, 2022, we employed 37 employees within sales and marketing compared to 33 employees as of September 30, 2021. None of our sales and marketing personnel transitioned with Cyren GmbH as part of the Cyren GmbH Transaction.


                                      -27-
--------------------------------------------------------------------------------
  Table of Contents
General and Administrative

For the three months ended September 30, 2022, general and administrative
expenses increased 0.7% compared to the same period in 2021. For the nine months
ended September 30, 2022, general and administrative expenses increased $0.7
million, or 11.3%, compared to the same period in 2021. This increase is
primarily due to an increase in expenses for outside service, consultants and
legal expenses, including costs associated with the Special Meeting of the
Company's shareholders held in February 2022, which accounted for a $0.4 million
increase year over year.

As of September 30, 2022, we employed 19 employees in general and administrative
functions compared to 27 employees as of September 30, 2021. Effective August 1,
2022, five employees transitioned with Cyren GmbH as part of the Cyren GmbH
Transaction .

Other Income (Expense), Net



For the three months ended September 30, 2022, other income, net decreased $8
thousand compared to the same period in 2021. For the nine months ended
September 30, 2022, other income, net decreased $7 thousand, compared to the
same period in 2021.

Financial Income (Expenses), Net



For the three months ended September 30, 2022, financial income (expenses), net,
increased $0.3 million compared to the same period in 2021. For the nine months
ended September 30, 2022, financial income (expenses), net, increased $0.8
million compared to the same period in 2021. These increases were driven by
changes in foreign exchange rates, as the significant decline in the Euro (EUR)
against the U.S. dollar (USD) during 2022 caused a reduction in certain of our
EUR-denominated liabilities.

Income Taxes

Effective Corporate Tax Rates

For the three and nine months ended September 30, 2022, corporate tax rates and real capital gains tax in Israel were 23%.

Cyren GmbH was subject to German tax at a consolidated rate of approximately 30%.

Other non-Israeli subsidiaries are taxed according to the tax laws in their respective countries of residence.



We do not provide deferred tax liabilities when we intend to reinvest earnings
of foreign subsidiaries indefinitely. As of September 30, 2022, we carried no
undistributed earnings of foreign subsidiaries.

We may qualify as an "industrial company" within the definition of the Law for
the Encouragement of Industry (Taxation) and, as such, we may be eligible for
certain tax benefits, including, inter alia, special depreciation rates for
machinery, equipment and buildings, amortization of patents, certain other
intangible property rights and deduction of share issuance expenses.

Net Operating Loss Carryforwards

As of December 31, 2021, Cyren Ltd.'s operating loss carryforwards for tax purposes amounted to $114.2 million. Capital loss carryforwards amounted to $17.8 million which may be carried forward and offset against taxable income in the future, for an indefinite period.



As of December 31, 2021, Cyren Inc., our U.S. subsidiary, had net operating loss
carryforwards of $42.8 million for federal tax purposes and $12.9 million for
state tax purposes. These losses may offset any future U.S. taxable income of
the U.S. subsidiary and will expire in the years 2022 through 2041.

Management currently believes that based upon its estimations for future taxable
income, it is more likely than not that the deferred tax assets regarding the
loss carryforwards will not be utilized in the foreseeable future. Thus, a
valuation allowance was provided as of September 30, 2022, to reduce deferred
tax assets to their realizable value.

                                      -28-

--------------------------------------------------------------------------------

Table of Contents

LIQUIDITY AND CAPITAL RESOURCES



The Company has incurred losses since inception and expects to continue to incur
losses for the foreseeable future. The Company intends to finance operating
costs over the next twelve months through a combination of utilizing existing
cash on hand, reducing operating spend, potentially divesting assets, and future
issuances of equity and/or debt securities.

As of September 30, 2022, we had an accumulated deficit of $296.6 million, and
cash and cash equivalents of $13.5 million. Current assets amounted to $17.9
million with current liabilities of approximately $13.9 million, resulting in
working capital of $4.0 million.

For the nine months ended September 30, 2022, we recorded a net loss of $25.0
million. We have incurred losses since inception and expect to continue to incur
losses for the foreseeable future. The current cash balance and historical trend
of cash used in operations along with the lack of certainty regarding a future
capital raise, provides substantial doubt about our ability to continue as a
going concern for the next twelve months from the date of issuance of this
Quarterly Report. The inability to borrow or raise sufficient funds on
commercially reasonable terms, would have serious consequences to our financial
condition and results of operations.

As previously discussed, on August 1, 2022, the Company completed the Cyren GmbH
Transaction and received the initial €9.4 million payment (equivalent to
$9.6 million as of the closing date). Under the terms of the SPA, a holdback in
the amount of €0.7 million (the "Holdback Amount") is currently held in an
escrow to satisfy certain claims. The Holdback Amount, less deductions for
claims against the Company, if any, will be released to the Company no later
than twelve months after the closing date.

Subsequent to the closing date, the Company has paid approximately $1.4 million
in expenses associated with the Cyren GmbH Transaction. Furthermore, the Company
estimates that the final purchase price will be reduced by $0.4 million based on
working capital and other adjustments and has accrued a current liability as of
September 30, 2022The Company is using the proceeds from the sale for working
capital and general corporate purposes.

Our future capital requirements will depend on many factors, including, but not
limited to our growth, market acceptance of our offerings, the timing and extent
of spending to support our efforts to develop our products, and the expansion of
sales and marketing activities based on our market opportunities. We expect to
require additional equity or debt financing. If additional financing is required
from outside sources, we may not be able to raise it on terms acceptable to us
or at all. If we issue additional equity securities to raise additional funds,
further dilution to existing shareholders may occur. However, we cannot predict
with certainty the outcome of our actions to generate liquidity, including the
availability of additional financing. If we are unable to raise additional
capital when desired, our business, financial condition, and results of
operations could be adversely affected.

Cash Flow Analysis

Cash Flows from Operating Activities



Our primary source of cash provided by operating activities is revenues
generated from sales of our services. Our primary uses of cash from operating
activities include personnel costs, costs associated with maintaining our data
centers and services necessary to support our customers.

Operating cash flow is calculated by adjusting our net loss for changes in
working capital, as well as by excluding non-cash items such as: depreciation,
non-cash operating lease expense, amortization expense of intangible assets,
share-based compensation, impairment of research and development capitalization,
amortization of deferred commissions, deferred taxes, net, non-cash interest
expense on the convertible notes and Convertible Debentures.

                                      -29-
--------------------------------------------------------------------------------
  Table of Contents
For the nine months ended September 30, 2022, cash used in operating activities
was $9.0 million as compared to cash used in operating activities of $12.5
million for the same period in 2021.

For the nine months ended September 30, 2022, the most significant factor
affecting our operating cash flows was our net loss of $25.0 million, which
included loss from discontinued operations of $6.9 million pertaining to the
Cyren GmbH sale. Net cash used by operating activities also was the result of
changes in operating lease liabilities of $1.7 million; prepaid expenses and
other receivables of $1.3 million; deferred commissions of $1.2 million; and
trade receivables of $0.9 million. This was partially offset by changes in
deferred revenues of $6.1 million; amortization of intangible assets of $1.7
million; share-based compensation of $1.6 million; employee and payroll
accruals, depreciation of $1.0 million and operating lease right-of-use asset of
$0.9 million.

For the nine months ended September 30, 2021, the primary factors affecting our
operating cash flows during the period were our net loss of $15.6 million, which
included income from continuing operations of 0.8 million pertaining to the
Cyren GmbH Transaction, and adjusted for non-cash items of $1.7 million of
stock-based compensation expense, $1.0 million for amortization of our non-cash
operating lease expense, $3.9 million for depreciation and amortization of our
property, equipment, and intangible assets, and $0.6 million for amortization of
deferred commissions. The primary drivers of the changes in operating assets and
liabilities were a $1.2 million decrease in operating lease liabilities, a $0.6
million decrease in capitalization of deferred commissions, a $0.6 million
decrease in prepaid expenses and other receivables, and a decrease in trade
receivables of $2.6 million.

Cash Flows from Investing Activities



Cash used in investing activities primarily consists of payments related to
capitalized technology, purchases of computer and network equipment to support
our data center infrastructure, and furniture and equipment. The extent of these
investments will be affected by our ability to expand relationships with
existing customers, grow our customer base, as well as constraints on cash
expenditures due to our financial position and the current economic environment.

For the nine months ended September 30, 2022, net cash used in investing activities was $7.2 million, consisting primarily of the proceeds from the Cyren GmbH sale.

For the nine months ended September 30, 2021, net cash used in investing activities was $0.4 million which primarily consisted of $0.3 million for capitalization of technology and $0.1 million used to purchase property and equipment.



Our capital expenditures over the last several years consisted primarily of
continued investment in research and development and purchases of property and
equipment to modernize and expand our data centers and to invest in our
infrastructure to support new products and facilitate the Company's growth. We
anticipate that capital expenditures for 2022 will be approximately $0.2
million.

Cash Flows from Financing Activities

The changes in cash flows from financing activities primarily relate to the issuance of the Convertible Debentures, and the issuance of ordinary shares and warrants to fund operations, offset by the repayment of debt upon maturity.



For the nine months ended September 30, 2022, net cash generated by financing
activities was $10.9 million as we issued to several institutional investors in
February 2022 in a private placement, 3,129,075 ordinary shares at a purchase
price of $3.835 per share (or ordinary share equivalent) and associated warrants
for net proceeds of approximately $10.9 million.

For the nine months ended September 30, 2021, net cash generated by financing
activities was $12.6 million as we issued to several institutional investors in
February 2021, in a registered direct offering 12,000,000 of our ordinary shares
at a purchase price of $1.15 per share for net proceeds of approximately $12.6
million.

                                      -30-
--------------------------------------------------------------------------------
  Table of Contents
Financings

On February 16, 2021, we issued to several institutional investors in a
registered direct offering, 600,000 of our ordinary shares at a purchase price
of $23.00 per share for net proceeds of approximately $12.6 million. We used the
proceeds from this offering for working capital and general corporate purposes.
We also issued to the placement agent or its designees warrants to purchase up
to 36,000 ordinary shares, representing 6% of the aggregate number of ordinary
shares sold in the offering. The placement agent warrants have an exercise price
equal to $28.75, or 125% of the offering price, per Ordinary Share and became
exercisable on August 16, 2021, for five years from the effective date of the
offering.

On September 17, 2021, we issued to several institutional investors in a private
placement, 707,639 of our ordinary shares at a purchase price of $14.40 per
share and warrants to purchase up to 707,639 ordinary shares at an exercise
price of $12.00 per share for net proceeds of approximately $10.2 million. We
used the gross proceeds from this offering for working capital and general
corporate purposes. The warrants were exercisable immediately and terminate on
March 17, 2025. We also issued to the placement agent or its designees warrants
to purchase up to 42,459 ordinary shares, representing 6.0% of the aggregate
number of ordinary shares sold in the offering. The placement agent warrants
have an exercise price equal to $18.00 per share, or 125% of the offering price
per share, were exercisable immediately and terminate on March 17, 2025.

On February 14, 2022, we issued to several institutional investors in a private
placement, 3,129,075 ordinary shares (or ordinary share equivalents) and
warrants to purchase up to 3,129,075 ordinary shares at a purchase price of
$3.835 per share (or ordinary share equivalent) and associated warrant for net
proceeds of approximately $12 million. We used the gross proceeds from this
offering for working capital and general corporate purposes. The warrants were
exercisable immediately, have an exercise price of $3.71 per ordinary share and
terminate on August 16, 2027. We also issued to the placement agent or its
designees warrants to purchase up to 187,745 ordinary shares, representing 6.0%
of the aggregate number of ordinary shares sold in the offering. The placement
agent warrants have an exercise price equal to $4.79 per share, or 125% of the
offering price per share, were exercisable immediately and terminate on February
15, 2027.

Registration Statements

On September 21, 2018, we filed a shelf registration statement on Form F-3 with
the SEC, which we converted to a Form S-3 on August 16, 2019. This registration
statement enables us to issue debt securities, ordinary shares, warrants or
subscription rights up to an aggregate amount of $50 million. Under the rules
governing shelf registration statements, we will file a prospectus supplement
with the SEC which describes the amount and type of securities being offered
each time we issue securities under this registration statement. In November
2019, we issued shares as part of our rights offerings and in February 2021, we
issued shares in the registered direct offering using our Form S-3 as described
above. On July 28, 2022, we filed a replacement shelf registration statement on
Form S-3 to replace the existing S-3 that expired on August 16, 2022.

Our market capitalization may limit our ability to raise additional capital in
the public markets. Although we are currently eligible to use our Form S-3, we
are limited to selling no more than one-third of our unaffiliated market
capitalization, or public float, on Form S-3 in a 12-month period as our public
float is below $75 million.

Outlook

The Company has incurred losses since inception and expects to continue to incur
losses for the foreseeable future. The Company intends to finance operating
costs over the next twelve months through a combination of utilizing existing
cash on hand, reducing operating spend, potentially divesting assets, and future
issuances of equity and/or debt securities.

The Company's ability to continue as a going concern is dependent upon growing
its business, obtaining the necessary financing to meet its obligations and
repay its liabilities arising from normal business operations. While the Company
intends to finance operating costs over the next twelve months through a
combination of existing cash on hand, reducing operating spend, potentially
divesting assets, and future issuances of equity and/or debt securities the
Company cannot predict the availability of additional financing or the outcome
of its actions to generate liquidity or maintain compliance with the Nasdaq
Capital Market listing standards.

                                      -31-
--------------------------------------------------------------------------------
  Table of Contents
At a Special Meeting of the Company's shareholders held on February 7, 2022, the
Company's shareholders approved a Reverse Share Split (including the relevant
amendments to the Articles of Association of the Company) within a range of 1:4
to 1:20, and amendments to the Company's Articles of Association authorizing an
increase in the Company's authorized share capital (and corresponding authorized
ordinary shares) by up to NIS 216 million. The board of directors approved the
implementation of a one-for-twenty Reverse Share Split and an increase in the
Company's authorized share capital by NIS 216 million to NIS 240 million. The
Reverse Share Split was effective on February 8, 2022, and the Company's
ordinary shares began trading on a split-adjusted basis on February 9, 2022.
Following the Reverse Share Split and increase in authorized share capital, the
total number of ordinary shares that the Company is authorized to issue is 80
million shares. While the Company was able to regain compliance with the Nasdaq
minimum bid price requirement in February 2022 following the effectiveness of
the Reverse Share Split, there can be no assurance that the Company will
continue to meet the Nasdaq listing requirements. The inability to remain listed
on Nasdaq may make it difficult for us to raise additional capital.

Over the past several years, the Company has devoted most of its effort to
research and development and increasing revenues through additional investments
in sales and marketing. For the nine months ended September 30, 2022, the
Company generated a net loss of $25.0 million and a negative cash flow from
operating activities of $9.0 million. For the year ended December 31, 2021, the
Company recorded a net loss of $23.0 million and a negative cash flow from
operating activities of $16.5 million. The Company has incurred losses since
inception and expects to continue to incur losses for the foreseeable future.

CRITICAL ACCOUNTING POLICIES AND ESTIMATES



Our significant accounting policies are discussed in Note 2 - Significant
Accounting Policies to our consolidated financial statements included in the
Company's 2021 Annual Report. There have been no significant changes to these
policies for the three months ended September 30, 2022, except as described in
Note 2 - Significant Accounting Policies to our condensed consolidated financial
statements in this Quarterly Report. The critical accounting policies requiring
estimates, assumptions, and judgments that we believe have the most significant
impact on our consolidated financial statements are described in Part II, Item
7. Management's Discussion and Analysis of Financial Condition and Results of
Operations included in our 2021 Annual Report.

Please refer to Note 2 - Significant Accounting Policies for a full description of recent accounting pronouncements.

Goodwill represents the excess of the purchase price over the estimated fair
value of net assets of a business acquired in a business combination. Under ASC
Topic 350, Intangibles - Goodwill and Other ("ASC 350"), goodwill is not
amortized, but rather is subject to impairment test at least annually. The
Company performs an annual impairment test as of December 31 of each year, or
more frequently if events or changes in circumstances indicate the carrying
value may not be recoverable. Goodwill is tested for impairment at the reporting
unit level by first performing a qualitative assessment to determine whether it
is more likely than not that the fair value of the reporting unit is less than
its carrying amount. If the reporting unit does not pass the qualitative
assessment, the Company carries out a quantitative test for impairment of
goodwill by comparing the fair value of the reporting unit with the carrying
amount of the reporting unit that includes goodwill. The Company may bypass the
qualitative assessment and proceed directly to performing the quantitative
goodwill impairment test.

The Company operates in one operating segment, and this segment comprises its only reporting unit.

December 31, 2021, 2020, no impairment losses were identified. For the three and nine months ended September 30, 2022, refer to Note 3.



It is possible that changes in circumstances existing at the measurement date or
at other times in the future, or in the numerous estimates associated with
management's judgments, assumptions and estimates made in assessing the fair
value of our goodwill, could result in an impairment charge of a portion or all
of our goodwill. If the Company recorded an impairment charge, its financial
position and results of operations would be adversely affected. For additional
information, see "Risk Factors" in Item 1A of Part II of this report. We will
continue to monitor certain events that impact our operations to determine if an
interim assessment of goodwill impairment should be performed prior to the next
required assessment date of December 31, 2022.

                                      -32-

--------------------------------------------------------------------------------

Table of Contents

RUSSIAN INVASION OF UKRAINE



We maintain sales operations, employees, and customers located in multiple
countries. We have contractors in Ukraine that assist in our operations group
which support our products. The ongoing military conflict between Ukraine and
Russia has resulted in minimal interruption of our operations in Ukraine and we
are developing alternative plans should our contractors not be available for a
period of time. While the precise effect of the ongoing military conflict and
the sanctions on the Russian and global economies remains uncertain, should
tensions continue to increase, financial markets may continue to experience
significant volatility as well as economic and security consequences.

While as of the date of this Quarterly Report there have not been any material impacts from the above-mentioned matter in our consolidated financial statements, we are continuously monitoring the developments to assess any potential future impacts that may arise as a result of the ongoing crisis.



Other potential consequences include, but are not limited to, growth in the
number of popular uprisings in the region, increased political discontent,
especially in the regions most affected by the conflict or economic sanctions,
increase in cyberterrorism activities and attacks, displacement of persons to
regions close to the areas of conflict and an increase in the number of refugees
fleeing across Europe, among other unforeseen social and humanitarian effects.

A protracted conflict between Ukraine and Russia, any escalation or expansion of
that conflict, and the financial and economic sanctions and the above-mentioned
adverse effect on the wider global economy and market conditions could, in turn,
have a material adverse effect on our business, financial condition and results
of operations

© Edgar Online, source Glimpses